I thought their problem was they didn't have access to vaccines over in Europe, not that they had a large stock to pick and choose from.
I thought their problem was they didn't have access to vaccines over in Europe, not that they had a large stock to pick and choose from.
Expected vaccine deliveries for Germany (pop. 80m):
Q1: Biontech 12.4m, Moderna 1.8m, AZ 5.7m
Q2: Biontech 40.2m, Moderna 6.4m, AZ 12.4-15.m, JJ: 10.1m, Curevac 1.4m
2021 (total): Biontech 100.7m, Moderna 78m, AZ: 56.3m, JJ: 36.7m, Curevac: 24.5m, Sanofi: 27.5
Source: https://www.bundesgesundheitsministerium.de/fileadmin/Dateie...
I guess it's a permanent problem if you're dead because of it.
A few thousand dead bodies at the current rate.
Wait - I thought France said AztraZeneca wasn't effective for people over 65? Are they just giving it to people 55-65 therefore? And shouldn't those people have already been vaccinated by now anyway?
Hang on that’s not not actually what the French said is it? They actually said there was data and that the data said it was ineffective.
> Everything points to thinking it is quasi-ineffective on people older than 65, some say those 60 years or older.
So they said there was data that said it was ineffective, not that there wasn't enough data.
Edit to add: ... and while Stiko, ie. the vaccination board, was quite clear on it, I'm sure there were like two dozen high ranking politicians in Germany in January who either didn't read or were unable to understand the Stiko recommendation and claimed that AZ is known to be ineffective. Most politicians aren't trained scientists, and unfortunately it shows.